Results 141 to 150 of about 9,297 (211)

<i>Leishmania</i> RNA Virus and Its Impact on Drug Response and Clinical Outcomes in Leishmaniasis: A Comprehensive Review. [PDF]

J Parasitol Res
Zolfaghari A, Seyedyousefi S, Shahmoradi Z, Zaker E, Esboei BR.   +4 more
europepmc   +1 more source

Characterization of GH18 chitinase in Leishmania braziliensis: expression, structural insights, and implications for vaccine and therapeutic development. [PDF]

Biol Res
Rojas-Pirela M, Chacón-Arnaude M, Lárez-Velásquez C, Rojas MV, Cardenas C, Cáceres AJ, Corchete LA, Andrade-Alviárez D, Prieto-Rojas LA, Salete-Granado D, Pérez-Nieto MÁ, Quiñones W, Michels PAM, Marcos M.   +13 more
europepmc   +1 more source

Fifteen-Year Evolution of Chronic Cutaneous Leishmaniasis Mimicking Other Dermatoses. [PDF]

Am J Trop Med Hyg
Hurtado-Rossi L, Gutierrez-Gomez M, Martinez-Valencia AJ, García-Luna JA.   +3 more
europepmc   +1 more source

Revisiting the past in light of current knowledge on γδ T cells in leishmaniasis. [PDF]

Front Immunol
Dos-Santos JS, de Matos Guedes HL.
europepmc   +1 more source

Synthesis and Antileishmanial Activity of Cinnamic Acid-Amantadine Amides. [PDF]

ACS Omega
Fernandes ÉB, de Freitas CS, Silva Viana LP, Moreira da Silva C, Guedes NA, Romão W, Lacerda V, Dos Santos NA, de Oliveira FM, da Silva DA, Cerceau CI, de Oliveira MB, Belarmino WDS, Campos Serpa QH, de Oliveira OV, Costa AV, Coelho EAF, Teixeira RR.   +17 more
europepmc   +1 more source

Response and therapeutic failure to meglumine antimoniate, the first-line drug for cutaneous leishmaniasis infections in Colombian soldiers. [PDF]

Parasitol Res
Pavia PX, Patiño LH, Méndez C, Romero Y, Duque MC, Cruz C, Ramírez JD.   +6 more
europepmc   +1 more source

Evidence Gaps and Global Patterns in Leishmaniasis Control: A Scoping Review of Clinical, Diagnostic, and Treatment Strategies. [PDF]

J Parasitol Res
Mohammed MW, Aboagye YO, Anyanful A, Kyei S, Asare KK.   +4 more
europepmc   +1 more source

<i>Crithidia fasciculata</i> Shows Non-Pathogenic Behavior in Leishmania Co-Infection Related to Temperature Stress, In Vitro and In Vivo Infections, and Amphotericin B Susceptibility. [PDF]

Microorganisms
Santos JFBD, Martins CB, Andrade-Neto VV, Lemos-Silva T, Dos Santos RF, Gonçalves da-Silva SA, Traub-Csekö YM, Menna-Barreto RFS, Torres-Santos EC, d'Avila CM, Ennes-Vidal V.   +10 more
europepmc   +1 more source

<i>In vitro</i> and <i>in vivo</i> studies of dehydroxylated-isoquines and -isotebuquines against trypanosomatids: a preclinical drug candidate for treatment of cutaneous leishmaniasis. [PDF]

RSC Med Chem
Romero AH, Serna E, Aguilera E, Davila B, Delgado F, Scalese G, Pérez-Díaz L, Yaluff G, Rodríguez N, Cerecetto H.   +9 more
europepmc   +1 more source

Revisiting Leishmania (Viannia) lainsoni Silveira, Shaw, Braga, and Ishikawa, 1987: current knowledge and emerging perspectives. [PDF]

Parasit Vectors
de Morais TG, Campos MB, Silveira FT, Vasconcelos Dos Santos T.   +3 more
europepmc   +1 more source